Human cytomegalovirus (HCMV) replication is limited by HCMV-specific natural killer (NK) cell response. Distinct genetic polymorphisms, which are potentially involved in antiviral NK cell response, have been described. Here, the association between polymorphisms at IgG1 genetic marker 3/17, FcγRIIIα/ CD16a 158V/F, NKG2C wt/del , CD226/rs727088, and rs763361, respectively, and HCMV viremia and disease were investigated in 98 lung transplant recipients (LTRs), within 9 months after stop of posttransplant HCMV prophylaxis. From all variants, only the NKG2C wt/wt genotype was significantly associated with freedom from HCMV viremia (P = .0002) and disease (P = .02), compared with the NKG2C wt/del genotype. Thus, LTRs expressing the homozygous NKG2C wild type seem to have a selective advantage in HCMV defense.
CITATION STYLE
Vietzen, H., Pollak, K., Honsig, C., Jaksch, P., & Puchhammer-Stöckl, E. (2018). NKG2C deletion is a risk factor for human cytomegalovirus viremia and disease after lung transplantation. Journal of Infectious Diseases, 217(5), 802–806. https://doi.org/10.1093/infdis/jix608
Mendeley helps you to discover research relevant for your work.